gen_82.1.gif
Announcement Topics Registration Abstracts Location Program

Preliminary program

 

Sunday, September 12th , 2010

From 16:30

Registration w. Apéro

 

18:00-19:30

Dinner

 

19:30-19:45

Official Opening of the ETW, Announcements

Sabine Geisse

19:45-20:45

1st Keynote Lecture:

Transposon-based vector systems for robust stable gene transfer and expression in vertebrate cells

 

Dr. Zolt án Ivics,

Max Delbrück Center for Molecular Medicine, Berlin, Germany

21:00

Cash Bar

 

 

Monday, September 13th, Morning Session

From 7:30

Breakfast

 

9:00-10:00

2 nd Keynote Lecture:

Novartis response to H1N1v - Production and preparation of a cell culture derived adjuvanted flu vaccine

Dr. Ulrich Valley,
Head Technology Development,
Novartis Vaccines & Diagnostics,
Marburg, Germany

10:00

1 st Session:

 

10:00-10:30

 

AGE1.HN - A human designer cell line provides a versatile production platform

Thomas Rose, ProBioGen AG, Berlin, Germany

10:30-11:00

 

CAP-T cell expression system: a novel rapid and versatile human cell expression system for fast and high yield transient protein expression

Jens Wölfel, Cevec Pharmaceuticals GmbH , Köln, Germany

11:00-11:30

Coffee Break

 

11:30-12:00

 

Improving animal cells process development with fluorescence-based methods

 

Ana P Teixeira, IBET / ITQB-UNL, Oeiras, Portugal

12:00-12:30

 

Recombinant protein modifications and the influences of bioprocessing operations

Nigel Jenkins,

Nat’l Inst. Bioprocessing Research & Training, Belfield, Dublin, Ireland

12:30-13:45

Lunch

 

 

 

Monday, September 13th, Afternoon Session

13:45

3rd Keynote Lecture:

Retroviral platforms for transient and permanent modification of stem cells

 

Prof. Christopher Baum,

Hannover Medical School, Experimental Hematology, D-30625 Hannover, Germany

14:45

2nd Session:

 

14:45-15:15

 

Sequence specific applications in cell line engineering to improve product quality and to increase its titer

Oliver Kraemer, University of Bielefeld, Germany

15:15-15:45

 

Recombinant FVIII purification antibody for manufacturing of N8

J.J. Hansen, Novo Nordisk A/S, Novo Nordisk Park, Maaloev, Denmark

15:45-16:1 5

Coffee Break

 

16:15-16:45

 

Fast, efficient and high quality cell line generation as key to success in development of biopharmaceuticals

Burkhard Wilms, Novartis Pharma AG, Switzerland

16:45-17:1 5

 

Identification of critical parameters influencing the success of transient protein production in CHO cells

Bernd Voedisch, Novartis Institutes for BioMedical Research, Basel, Switzerland

17:15-19:30

Poster Viewing with Apéro

 

19:30

Dinner

 

21:00

Cash Bar

 

 

Tuesday, September 14th, Morning Session

From 7:00

Breakfast

9:00-10:00

4th Keynote Lecture:
Synthetic biology in mammalian cells and materials science

Prof. Wilfried Weber,
bioss Centre for Biological Signalling Studies, Albert-Ludwigs Universität Freiburg, Germany

10:00

3rd Session:

 

10:00-10:30

The evolution of single use bioreactors: design, application and validation

 

Roman Rodriguez, ATMI Life Sciences, Hoegaarden, Belgium

10:30-11:00

Investigation of orbitally shaken bioreactor hydrodynamics

 

Martino Reclari, Lab.Cellular Biotechnology, EPFL SV-IBI-LBTC, Lausanne, Switzerland

11:00-11:30

Coffee Break

 

 

11:30-12:00

Predictive metabolic flux analysis as a powerful tool to assist bioprocess optimization

Nuno Carinhas, IBET/ITQB/FCT, Universidade Nova de Lisboa, Portugal

12:00-12:30

Biomolecule production using PEI-mediated transient transfection

Patrick Erbacher, Polyplus-transfection S.A., Illkirch, France

12:30-12:45

Wrap-up and Closing of the Workshop

 

12:45

Lunch

 

14:00

Departure; Optional: Tour of the Cloister